Go to article
Posted by CoV Report on May 8, 2024 11:46 amTags: Categories: Global Stories
AstraZeneca says a surplus of other available COVID-19 vaccines and declining demand are the reasons behind why it’s withdrawing Vaxzevria.
Your email address will not be published. Required fields are marked *
Comment *
Name *
Email *
Website
Save my name, email, and website in this browser for the next time I comment.
< The Coronavirus Report home
Everything you need to know to stay updated on the Coronavirus
Leave a Reply